|
Q1 FY2025
As of Jun 30, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q3 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
Q1 FY2022
As of Jun 30, 2021
|
Q4 FY2021
As of Mar 31, 2021
|
Q3 FY2021
As of Dec 31, 2020
|
Q2 FY2021
As of Sep 30, 2020
|
Q1 FY2021
As of Jun 30, 2020
|
Q4 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalent | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments and amounts in escrow (Note 3) | ||||||||||||||||||||
| Short-term investments and amounts in escrow | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $162,000 in June 30, 2024 and $195,000 in March 31, 2024 | ||||||||||||||||||||
| Other receivables, net of allowance for credit losses of $4,000 in June 30, 2024 and $32,000 in March 31, 2024 | ||||||||||||||||||||
| Other receivable, net of allowance for doubtful accounts of $nil and $3,951 at September 30, 2023 and March 31, 2023, respectively (Note 4) | ||||||||||||||||||||
| Accrued revenue (Note 11) | ||||||||||||||||||||
| Accrued revenue (Note 8) | ||||||||||||||||||||
| Due from related parties (Note 11) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due from related parties (Note 11) | ||||||||||||||||||||
| Prepaid expenses, parts inventory, and advances | ||||||||||||||||||||
| Prepaid manufacturing costs (Note 8) | ||||||||||||||||||||
| Projects under development (Note 5) | ||||||||||||||||||||
| Projects under development (Note 3) | ||||||||||||||||||||
| Loan receivable (Note 4) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Lease receivable (Note 4) | ||||||||||||||||||||
| Asset held for sale (Note 4) | ||||||||||||||||||||
| Project under development | ||||||||||||||||||||
| Assets held for sale (Note 5) | ||||||||||||||||||||
| Projects under development (Note 3) | ||||||||||||||||||||
| Property and equipment (Note 5) | ||||||||||||||||||||
| Intangible assets (Note 6) | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Security deposits and other advances (Note 4) | ||||||||||||||||||||
| Deferred tax assets (Note 21) | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Investment and other advances | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities (Note 9) | ||||||||||||||||||||
| Warranty provision | ||||||||||||||||||||
| Contract liabilities (Note 11) | ||||||||||||||||||||
| Contract liabilities (Note 8) | ||||||||||||||||||||
| Loans payable (Note 10) | ||||||||||||||||||||
| Loans of Projects Under Development (Note 13) | ||||||||||||||||||||
| Current portion of lease obligations | ||||||||||||||||||||
| Due to related parties (Note 13) | ||||||||||||||||||||
| Due to related parties (Note 16) | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Interest payable (Note 10) | ||||||||||||||||||||
| Due to related parties (Note 11) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total due to related parties (Note 11) | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term accounts payable and accrued liabilities (Note 11) | ||||||||||||||||||||
| Non – current portion of lease obligation (Note 14(a)) | ||||||||||||||||||||
| Long term loans payable (Note 11) | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other long term obligations | ||||||||||||||||||||
| Long-term operating lease obligations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, 500,000,000 shares authorized, $0.001 par value 56,845,724 and 52,345,724 shares issued and outstanding, June 30, 2024 and March 31, 2024 respectively (Note 12) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Deficit | ||||||||||||||||||||
| Total stockholders’ equity before treasury stock | ||||||||||||||||||||
| Total stockholders’ (deficit) equity | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest (Note 7) | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...